U008 Laser and Device-based Treatment of Scars
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
This session will explore the use of lasers and device-based technology to treat different types of scars. Traditional and cutting-edge techniques will be explored for the correction of erythematous, pigmented, hypertrophic and atrophic scars, acne scars, burn scars, surgical scars and complex scars from trauma. Session format will include lectures and panel discussion.
LEARNING OBJECTIVES
Categorize scar types.
Identify new devices and techniques for treating scars.
Use an algorithmic approach to choose the most appropriate therapies for different scar types.
SCHEDULE
12:30 PM
Introduction
Arielle N.B. Kauvar, MD, FAAD
12:32 PM
Instrumentation, Scar Type and Skin Type
Kristen Marie Kelly, MD, FAAD
12:44 PM
Surgical and Trauma Scars
Arielle N.B. Kauvar, MD, FAAD
12:56 PM
Acne Scar Treatment
Girish S. Munavalli, MD, MHS, FAAD
1:08 PM
Burn and Trauma Scar Innovations
Jill S. Waibel, MD, FAAD
1:20 PM
Discussion / Q & A
SPEAKERS
Arielle N.B. Kauvar, MD, FAAD
Kristen Marie Kelly, MD, FAAD
Girish S. Munavalli, MD, MHS, FAAD
Jill S. Waibel, MD, FAAD
SPEAKER DISCLOSURES
Arielle N.B. Kauvar, MD, FAAD
Candela Corporation – Investigator(Grants/Research Funding); Lumenis – Investigator(Grants/Research Funding); Sofwave – Investigator(Grants/Research Funding);
Kristen Marie Kelly, MD, FAAD
BioPhotas Inc. – Investigator(Grants/Research Funding); Candela Corporation – Other(Equipment), Other(No Compensation Received); Cutera – Other(Equipment); Lutronic – Investigator(Equipment), Investigator(Grants/Research Funding); Michaelson Diagnostics – Investigator(Equipment); Michelson Diagnostics – Investigator(Grants/Research Funding); NobelPharma – Consultant (1099 relationship)(Honoraria); Orlucent – Investigator(Grants/Research Funding); Primus Pharmaceuticals – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); R2 Dermatology, Inc. – Investigator(Equipment); Reliant Technologies, Inc. – Other(Equipment); Sciton Inc. – Investigator(Equipment); Sciton, Inc. – Consultant(Honoraria); Shanghai Fudan-Zhangjiang Bio Pharmaceutical Co., Ltd. – Consultant(Honoraria), Investigator(Grants/Research Funding); Thermage – Other(Equipment);
Girish S. Munavalli, MD, MHS, FAAD
AbbVie – Investigator(Grants/Research Funding); Benev – Investigator(Grants/Research Funding); Candela Corporation – Advisory Board(Honoraria); Lumenis – Investigator(Equipment); Sofwave – Investigator(Stock Options);
Jill S. Waibel, MD, FAAD
Allergan – Consultant (1099 relationship)(Honoraria); Amgen – Investigator(Grants/Research Funding); argenx – Investigator(Grants/Research Funding); BellaMia Technologies Inc. – Advisory Board(No Compensation Received); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Candela Corporation – Consultant (1099 relationship)(Honoraria); Cytrellis Biosystems, Inc – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding), Speaker(No Compensation Received); Galderma – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Johnson & Johnson Innovative Medicine – Investigator(Grants/Research Funding); Lumenis – Advisory Board(Honoraria), Consultant (1099 relationship)(No Compensation Received), Speaker(Honoraria); Neuronetics NeuroStar – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Procter & Gamble Company – Consultant (1099 relationship)(Honoraria); Regenx – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); Shanghai Fudan-Zhangjiang Bio Pharmaceutical Co., Ltd. – Investigator(Grants/Research Funding); SkinCeuticals LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); VA Merit Grant – Other(No Compensation Received);